BRTTH rolls out second dose COVID-19 vaccination

Author: Cyra S. Corral
Co-Author: Bianca Marie Danao


Protection is better than cure.

In support for the COVID-19 vaccination activity of the Department of Health (DOH), Bicol Regional Training and Teaching Hospital (BRTTH) rolled out its Sinovac second dose vaccination to its 944 healthcare workers on April 2-7, 2021.

As DOH encouraged frontliners to get the earliest available vaccines, the first dose vaccination for COVID-19 in BRTTH was conducted to its 130 healthcare workers last March 5, 2021.

To further mitigate the spread of the virus and protect the most vulnerable, BRTTH extended the vaccination activity until April 8, 2021 to also accommodate Bureau of Fire (BFP), Department of Health-Center for Health Development (DOH-CHD), Food and Drug Administration (FDA), as well as the other BRTTH health care workers who were not included in the previous vaccination schedule.


The vaccine recipients underwent screening and classification for allergies and comorbidities.

Day 1: The vaccine recipients on April 2, 2021 were the vaccination team, with a total of 118 vaccines of Sinovac 2nd dose out of 130.

1    2


Day 2: The vaccine recipients on April 5, 2021 were the employees of BRTTH with a total of 284 vaccines of Sinovac 2nd dose out of 306.

3  4


Day 3: The vaccine recipients on April 6, 2021 were BRTTH health workers with a total of 342 vaccines of Sinovac 2nd dose from the total scheduled vaccine of 278, including the no show and deferred vacccines from April 2 and April 5.

5  6


Day 4: The vaccine recipientsbon April 7, 2021 were BRTTH health workers with a total of 134 vaccines of Sinovac 2nd dose out of 230.

7  8


Day 5: On April 8, 2021 the vaccine recipients for first dose were the Bureau of Fire (BFP) and the Food and Drug Administration (FDA).

9  10 

      11       12


The pandemic has been affecting the entire social, economic and health system and has laid bare its fragility.

The importance of vaccination and the need to develop herd immunity against COVID-19 is in dire need.

This vaccine is an important tool to help the community and also a safer way to help build protection against the virus.